Printer Friendly
The Free Library
14,558,173 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chugai Pharmaceutical Now Features Disease Information Website in Japanese.


Tokyo, Japan, Dec 19, 2005 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Chugai Pharmaceutical announced on December 19 that it has opened Health Kiosk, a Japanese-language disease information website for the public, on its official homepage.

Based on Health Kiosk organized by its strategic partner F. Hoffman La-Roche (Roche),the Japanese site covers eight major diseases and symptoms: cancer, osteoporosis, cardiovascular disease Cardiovascular disease
Disease that affects the heart and blood vessels.

Mentioned in: Lipoproteins Test

cardiovascular disease 
, type 2 diabetes type 2 diabetes
n.
See diabetes mellitus.
, influenza, hepatitis C, HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  and overweight. Health Kiosk describes these diseases and symptoms in terms clearly understandable to laymen.

Roche's Health Kiosk website is now available in five languages: English, German, French, Spanish and Japanese. With this move, Chugai aims to educate the public by providing useful information.

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Dec 20, 2005
Words:118
Previous Article:Medinet, University of Tokyo Hospital Jointly Undertake Animal Experiments for Immune Cell Therapy.
Next Article:Japan Lifeline Launches Improved PTCA Balloon Catheter.



Related Articles
Chugai Pharmaceutical Discloses Clinical Trial Information through JAPIC Website.
Combination Therapy Using Chugai Pharmaceutical's Chronic Hepatitis-C Agents PEGASYS and Rivabirin Granted Priority Review Status by Government.
Chugai Pharmaceutical Renovates Its Website for Actemra, Drug for the Castleman's Disease.
Tokyo District Court Dismisses Ajinomoto's Patent Infringement Case against Chugai Pharmaceutical.
Chugai Files NDA for an Anti-Tumor Agent, Erlotinib (Epidermal Growth Factor Receptor (EGFR/HER1) Tyrosine Kinase Inhibitor).
Chugai Announces Japanese Phase III Trial Data Demonstrates Efficacy of 'Actemra(R),' a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, on...
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484.
Chugai to Launch HIV Protease Inhibitor INVIRASE(R) Tablet 500mg on September 15.
Chugai Pharmaceutical to Establish an Oncology Unit.
Anti-Cancer Agent Avastin(R) Approved in Japan.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles